Who are the key players in Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market?

Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca and Bristol Myers Squibb are the major companies operating in the Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market. Read More

What years does this Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market cover, and what was the market size in 2023?

In 2023, the Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market size was estimated at USD 1.67 billion. The report covers the Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Asia-Pacific Sodium-dependent Glucose Cotransporter 2 (SGLT-2) Market Share

Q: How big is the Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market?

The Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market size is expected to reach USD 1.82 billion in 2024 and grow at a CAGR of 8.35% to reach USD 2.72 billion by 2029. Read More

Q: What is the current Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market size?

In 2024, the Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market size is expected to reach USD 1.82 billion. Read More

Statistics for the 2023 & 2024 Asia-Pacific Sodium-dependent Glucose Cotransporter 2 (SGLT-2) market share, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Sodium-dependent Glucose Cotransporter 2 (SGLT-2) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Asia-Pacific Sodium-dependent Glucose Cotransporter 2 (SGLT-2) Industry

The Asia-Pacific Sodium-dependent Glucose Cotransporter 2 (SGLT-2) Market is highly consolidated, with major manufacturers, namely Eli Lilly, Sanofi, and Novo Nordisk, with a global and regional market presence. The joint ventures that occurred between players in the recent past helped the companies strengthen their market presence. For example, Eli Lilly and Boehringer Ingelheim make Jardiance together, which is a very popular SGLT-2 class drug.